Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Hewitt Website

Stephen M. Hewitt, M.D., Ph.D.

Selected Publications

1)  Cho H, Kim S, Shin HY, Chung EJ, Kitano H, Hyon Park J, Park L, Chung JY, Hewitt SM, Kim JH.
Expression of stress-induced phosphoprotein1 (STIP1) is associated with tumor progression and poor prognosis in epithelial ovarian cancer.
Genes Chromosomes Cancer. 53: 277-88, 2014.
[Journal]
2)  Armani M, Tangrea M, Yang B, Rosenberg A, Ylaya K, Morris J, Rodriguez-Canales J, Hanson J, Shapiro B, Emmert-Buck MR, Smela E, Hewitt SM.
Multiplex Quantitative Measurement of mRNAs From Fixed Tissue Microarray Sections.
Diagn. Mol. Pathol. 2014.
[Journal]
3)  Kitano H, Chung JY, Ylaya K, Conway C, Takikita M, Fukuoka J, Doki Y, Hanaoka J, Hewitt SM.
Profiling of Phospho-AKT, Phospho-mTOR, Phospho-MAPK and EGFR in Non-small Cell Lung Cancer.
J. Histochem. Cytochem. 2014.
[Journal]
4)  Hembrough T, Thyparambil S, Liao WL, Darfler MM, Abdo J, Bengali KM, Hewitt SM, Bender RA, Krizman DB, Burrows J.
Application of Selected Reaction Monitoring for Multiplex Quantification of Clinically Validated Biomarkers in Formalin-Fixed, Paraffin-Embedded Tumor Tissue.
J Mol Diagn. 2013.
[Journal]
5)  Horne HN, Sherman ME, Garcia-Closas M, Pharoah PD, Blows FM, Yang XR, Hewitt SM, Conway CM, Lissowska J, Brinton LA, Prokunina-Olsson L, Dawson SJ, Caldas C, Easton DF, Chanock SJ, Figueroa JD.
Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression.
Breast Cancer Res. Treat. 2013.
[Journal]
6)  Dan T, Hewitt SM, Ohri N, Ly D, Soule BP, Smith SL, Matsuda K, Council C, Shankavaram U, Lippman ME, Mitchell JB, Camphausen K, Simone NL.
CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-up.
Breast Cancer Res. Treat. 2013.
[Journal]
7)  Antony S, Wu Y, Hewitt SM, Anver MR, Butcher D, Jiang G, Meitzler JL, Liu H, Juhasz A, Lu J, Roy KK, Doroshow JH.
Characterization of NADPH oxidase 5 expression in human tumors and tumor cell lines with a novel mouse monoclonal antibody.
Free Radic. Biol. Med. 65C: 497-508, 2013.
[Journal]
8)  Camargo MC, Kim WH, Chiaravalli AM, Kim KM, Corvalan AH, Matsuo K, Yu J, Sung JJ, Herrera-Goepfert R, Meneses-Gonzalez F, Kijima Y, Natsugoe S, Liao LM, Lissowska J, Kim S, Hu N, Gonzalez CA, Yatabe Y, Koriyama C, Hewitt SM, Akiba S, Gulley ML, Taylor PR, Rabkin CS.
Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis.
Gut. 2013.
[Journal]
9)  Kim BW, Cho H, Chung JY, Conway C, Ylaya K, Kim JH, Hewitt SM.
Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry.
J Transl Med. 11: 185, 2013.
[Journal]
10)  Kapanadze T, Gamrekelashvili J, Ma C, Chan C, Zhao F, Hewitt S, Zender L, Kapoor V, Felsher DW, Manns MP, Korangy F, Greten TF.
Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.
J. Hepatol. 59: 1007-13, 2013.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 3/7/2014.